Entrada Therapeutics, Inc. SEC filings TRDA
Entrada Therapeutics, Inc. has 472 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 10, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 24, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| 144/A | Filing | Aug 10, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 144 | Notice of proposed sale | Jul 30, 2026 | — |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 144 | Notice of proposed sale | May 4, 2026 | — |
| 144 | Notice of proposed sale | May 4, 2026 | — |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 25, 2025 | — |
| 4 | Insider transaction | Nov 24, 2025 | Nov 21, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 144 | Notice of proposed sale | Nov 21, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 18, 2025 | — |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 144 | Notice of proposed sale | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| S-3 | Shelf registration | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 9, 2025 |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 144 | Notice of proposed sale | Jun 30, 2025 | — |
| 144 | Notice of proposed sale | Jun 30, 2025 | — |
| 144 | Notice of proposed sale | Jun 27, 2025 | — |
| 144 | Notice of proposed sale | Jun 27, 2025 | — |
| 4/A | Form 4/a | Jun 18, 2025 | May 13, 2024 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| 3 | Initial insider ownership | Jun 3, 2025 | Jun 1, 2025 |
| DEFA14A | Additional proxy material | Jun 3, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 3, 2025 | May 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Exit or restructuring costs
|
Apr 29, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 3, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 144 | Notice of proposed sale | Mar 17, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 24, 2025 | Feb 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 15, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 4 | Insider transaction | Nov 6, 2024 | Nov 4, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 144 | Notice of proposed sale | Oct 16, 2024 | — |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 10, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 10, 2024 | Sep 6, 2024 |
| 4 | Insider transaction | Sep 10, 2024 | Sep 6, 2024 |
| 144 | Notice of proposed sale | Sep 9, 2024 | — |
| 144 | Notice of proposed sale | Sep 6, 2024 | — |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 144 | Notice of proposed sale | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Jul 16, 2024 | Jul 12, 2024 |
| 4 | Insider transaction | Jul 16, 2024 | Jul 12, 2024 |
| 144 | Notice of proposed sale | Jul 15, 2024 | — |
| 144 | Notice of proposed sale | Jul 12, 2024 | — |
| 4 | Insider transaction | Jul 10, 2024 | Jul 8, 2024 |
| 144 | Notice of proposed sale | Jul 8, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 26, 2024 | — |
| 4 | Insider transaction | Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| 424B5 | Prospectus supplement | Jun 24, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 24, 2024 | Jun 24, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 144 | Notice of proposed sale | Jun 13, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 14, 2024 |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| 4 | Insider transaction | May 10, 2024 | May 8, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 144 | Notice of proposed sale | Apr 30, 2024 | — |
| 144 | Notice of proposed sale | Apr 29, 2024 | — |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 13, 2024 |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| 144 | Notice of proposed sale | Apr 25, 2024 | — |
| 144 | Notice of proposed sale | Apr 24, 2024 | — |
| 144 | Notice of proposed sale | Apr 23, 2024 | — |
| 144 | Notice of proposed sale | Apr 19, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 13, 2024 |
| 144 | Notice of proposed sale | Apr 18, 2024 | — |
| 144 | Notice of proposed sale | Apr 17, 2024 | — |
| 144 | Notice of proposed sale | Apr 16, 2024 | — |
| 144 | Notice of proposed sale | Apr 15, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1689375
- Former names
- CycloPorters, Inc. (until Nov 10, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.